Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cilengitide (EMD 121974) is a molecule designed and synthesized at the Technical University of Munich in collaboration with Merck KGaA in Darmstadt. It is based on the cyclic peptide cyclo(-RGDfV-), which is selective for αv integrins, which are important in angiogenesis (forming new blood vessels), and other aspects of tumor biology. Hence, it is under…
The analysis highlights Standards and Products as prominent areas in the source structure around Cilengitide.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Cilengitide shows recurring relationship patterns in the source. For example, Cilengitide → I/IIa, MGMT, Phase II. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
glioblastoma radiation tumor standard able angiogenesis patients status inhibiting cytotoxic effects 40 model references phase newly diagnosed mgmt promoter drug
TTTA extracted 3 structured relationships around Cilengitide. Examples in this analysis include Cilengitide → related to Clinical trials → Phase II and Cilengitide → related to Clinical trials → MGMT. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cilengitide | related to Clinical trials | Phase II | 0.60 | section |
| Cilengitide | related to Clinical trials | MGMT | 0.60 | section |
| Cilengitide | related to Clinical trials | I/IIa | 0.60 | section |
The concept neighborhoods around Cilengitide bring nearby vocabulary together. In this analysis, examples include Glioblastoma, Patients and Radiation. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Cilengitide, one of the stronger structural bridges in this analysis connects Cilengitide with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Cilengitide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Standards & Products, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Cilengitide · EN edition · Analysis: TopicsToTalkAbout